Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v8-FR
Language English French
Date Updated 2023-06-21 2023-06-14
Drug Identification Number 02422956 02422956
Brand name ALPROLIX ALPROLIX
Common or Proper name ALPROLIX ALPROLIX
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN
Strength(s) 3000UNIT 3000UNIT
Dosage form(s) POWDER FOR SOLUTION KIT POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 1
ATC code B02BD B02BD
ATC description VITAMIN K AND OTHER HEMOSTATICS VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2023-05-15 2023-05-15
Estimated end date 2023-06-20 2023-06-20
Actual end date 2023-06-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Reason for the shortage- Overselling Reason for the shortage- Overselling
Health Canada comments